Symphony Financial, Ltd. Co. Exelixis, Inc. Transaction History

Symphony Financial, Ltd. Co.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$16.3 - $19.41 $42,412 - $50,504	-2,602 Reduced 7.75%	30,958 $600,000
Q4 2022 Jan 26, 2023	SELL	$14.96 - $17.39 $24,998 - $29,058	-1,671 Reduced 4.74%	33,560 $0
Q3 2022 Oct 27, 2022	BUY	$15.68 - $22.27 $552,422 - $784,594	35,231 New	35,231 $558,000

502

243M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.9B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Symphony Financial, Ltd. Co., based on Form 13F filings with the SEC.

Stay updated on Symphony Financial, Ltd. Co. with notifications on news.